You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
旗濱集團(601636.SH):湖南藥玻擬投建中性硼硅藥用玻璃素管生產線項目(二期)
格隆匯 11-01 17:55

格隆匯11月1日丨旗濱集團(601636.SH)公佈,公司的控股孫公司湖南旗濱醫藥材料科技有限公司(“湖南藥玻”)的中性硼硅藥用玻璃素管生產線項目(一期)已於2021年1月建成點火,4月份進入試產、試製階段,10月項目已進入商業化運營。目前,產品的成品率逐步提升,品牌效應初步顯現。近年來,藥用包裝材料受多政策助推,中硼硅玻璃替代空間增大,發展前景廣闊,根據公司戰略發展規劃和湖南藥玻目前的實際運營情況,為抓住市場發展機遇,解決產能瓶頸,湖南藥玻擬投資建設中性硼硅藥用玻璃素管生產線項目(二期),項目計劃總投資2.3267億元。該項目擬建40t/d一窯三線中性硼硅藥用玻璃素管生產線項目(二期)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account